Format
Sort by

Send to

Choose Destination

Selected items

Items: 7

1.

Structural Features of Antiviral APOBEC3 Proteins are Linked to Their Functional Activities.

Kitamura S, Ode H, Iwatani Y.

Front Microbiol. 2011 Dec 21;2:258. doi: 10.3389/fmicb.2011.00258.

2.
3.

Leveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS.

Hultquist JF, Harris RS.

Future Virol. 2009 Nov 1;4(6):605.

4.

Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics.

Albin JS, Harris RS.

Expert Rev Mol Med. 2010 Jan 22;12:e4. doi: 10.1017/S1462399409001343. Review.

5.

Host restriction of HIV-1 by APOBEC3 and viral evasion through Vif.

Niewiadomska AM, Yu XF.

Curr Top Microbiol Immunol. 2009;339:1-25. doi: 10.1007/978-3-642-02175-6_1. Review.

PMID:
20012521
6.

Multiple ways of targeting APOBEC3-virion infectivity factor interactions for anti-HIV-1 drug development.

Smith JL, Bu W, Burdick RC, Pathak VK.

Trends Pharmacol Sci. 2009 Dec;30(12):638-46. doi: 10.1016/j.tips.2009.09.006. Review.

7.

Distinct domains within APOBEC3G and APOBEC3F interact with separate regions of human immunodeficiency virus type 1 Vif.

Russell RA, Smith J, Barr R, Bhattacharyya D, Pathak VK.

J Virol. 2009 Feb;83(4):1992-2003. doi: 10.1128/JVI.01621-08.

Items per page

Supplemental Content

Support Center